TFF PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 27th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2019 Company Industry JurisdictionThe undersigned, TFF Pharmaceuticals, Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), a company formed under the laws of Delaware, hereby confirms its agreement with National Securities Corporation (hereinafter referred to as the “Representative”), a Washington corporation, and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
CONSULTING AGREEMENTConsulting Agreement • September 27th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 27th, 2019 Company IndustryTHIS CONSULTING AGREEMENT (this “Agreement”), is made by and between TFF Pharmaceuticals, Inc, a Delaware Corporation with its principal place of business at 2801 Via Fortuna, Suite 425, Austin, Texas 78746 (“Company”), and James Brian Windsor, an individual having an address of 5703 Magee Bend, Austin, Texas 78749 (“Consultant”). Company and Consultant shall, at times throughout this Agreement, be referred to individually as a “Party” and collectively as the “Parties”.